US Stock MarketDetailed Quotes

APTO Aptose Biosciences

Watchlist
  • 0.2790
  • +0.1088+63.92%
Close Dec 20 16:00 ET
  • 0.2250
  • -0.0540-19.35%
Post 20:01 ET
16.61MMarket Cap-0.10P/E (TTM)

Aptose Biosciences Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-40.37%6.97M
-49.18%7.35M
-30.76%9.76M
22.90%52.36M
16.57%12.13M
16.51%11.68M
35.41%14.45M
22.57%14.1M
-34.91%42.6M
-57.27%10.4M
Selling and administrative expenses
-33.85%2.26M
-24.13%2.93M
-37.17%3.31M
7.68%15.54M
-16.79%3M
-0.26%3.42M
16.52%3.86M
28.81%5.27M
-25.31%14.43M
-12.10%3.61M
-General and administrative expense
-33.85%2.26M
-24.13%2.93M
-37.17%3.31M
7.68%15.54M
-16.79%3M
-0.26%3.42M
16.52%3.86M
28.81%5.27M
-25.31%14.43M
-12.10%3.61M
Research and development costs
-43.05%4.7M
-58.30%4.41M
-26.85%6.45M
30.89%36.77M
34.53%9.12M
25.51%8.26M
44.15%10.58M
19.18%8.81M
-38.92%28.09M
-66.47%6.78M
Depreciation amortization depletion
-60.00%4K
-58.33%5K
-66.67%6K
-39.51%49K
-55.56%8K
-58.33%10K
-42.86%12K
0.00%18K
-41.30%81K
-47.06%18K
-Depreciation and amortization
-60.00%4K
-58.33%5K
-66.67%6K
-39.51%49K
-55.56%8K
-58.33%10K
-42.86%12K
0.00%18K
-41.30%81K
-47.06%18K
Operating profit
40.37%-6.97M
49.18%-7.35M
30.76%-9.76M
-22.90%-52.36M
-16.57%-12.13M
-16.51%-11.68M
-35.41%-14.45M
-22.57%-14.1M
34.91%-42.6M
57.27%-10.4M
Net non-operating interest income expense
-94.83%12K
-71.47%93K
-71.33%121K
46.07%1.15M
-57.36%171K
-8.66%232K
193.69%326K
1,818.18%422K
738.30%788K
1,722.73%401K
Non-operating interest income
-94.83%12K
-71.47%93K
-71.33%121K
46.07%1.15M
-57.36%171K
-8.66%232K
193.69%326K
1,818.18%422K
738.30%788K
1,722.73%401K
Other net income (expense)
50.00%-1K
77.78%-2K
-50.00%1K
140.00%2K
0.00%-3K
33.33%-2K
-800.00%-9K
0.00%2K
Gain on sale of security
----
----
50.00%-1K
77.78%-2K
-50.00%1K
140.00%2K
0.00%-3K
33.33%-2K
-800.00%-9K
0.00%2K
Income before tax
39.26%-6.95M
48.67%-7.25M
29.51%-9.64M
-22.44%-51.21M
-19.55%-11.96M
-17.08%-11.45M
-33.73%-14.13M
-19.12%-13.68M
36.01%-41.82M
58.89%-10M
Income tax
Net income
39.26%-6.95M
48.67%-7.25M
29.51%-9.64M
-22.44%-51.21M
-19.55%-11.96M
-17.08%-11.45M
-33.73%-14.13M
-19.12%-13.68M
36.01%-41.82M
58.89%-10M
Net income continuous Operations
39.26%-6.95M
48.67%-7.25M
29.51%-9.64M
-22.44%-51.21M
-19.55%-11.96M
-17.08%-11.45M
-33.73%-14.13M
-19.12%-13.68M
36.01%-41.82M
58.89%-10M
Minority interest income
Net income attributable to the parent company
39.26%-6.95M
48.67%-7.25M
29.51%-9.64M
-22.44%-51.21M
-19.55%-11.96M
-17.08%-11.45M
-33.73%-14.13M
-19.12%-13.68M
36.01%-41.82M
58.89%-10M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
39.26%-6.95M
48.67%-7.25M
29.51%-9.64M
-22.44%-51.21M
-19.55%-11.96M
-17.08%-11.45M
-33.73%-14.13M
-19.12%-13.68M
36.01%-41.82M
58.89%-10M
Basic earnings per share
78.98%-0.37
81.06%-0.43
67.12%-0.73
-11.47%-7.58
11.66%-1.44
-10.69%-1.76
-31.98%-2.27
-23.33%-2.22
37.90%-6.8
59.75%-1.63
Diluted earnings per share
78.98%-0.37
81.06%-0.43
67.12%-0.73
-11.47%-7.58
11.66%-1.44
-10.69%-1.76
-31.98%-2.27
-23.33%-2.22
37.90%-6.8
59.75%-1.63
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -40.37%6.97M-49.18%7.35M-30.76%9.76M22.90%52.36M16.57%12.13M16.51%11.68M35.41%14.45M22.57%14.1M-34.91%42.6M-57.27%10.4M
Selling and administrative expenses -33.85%2.26M-24.13%2.93M-37.17%3.31M7.68%15.54M-16.79%3M-0.26%3.42M16.52%3.86M28.81%5.27M-25.31%14.43M-12.10%3.61M
-General and administrative expense -33.85%2.26M-24.13%2.93M-37.17%3.31M7.68%15.54M-16.79%3M-0.26%3.42M16.52%3.86M28.81%5.27M-25.31%14.43M-12.10%3.61M
Research and development costs -43.05%4.7M-58.30%4.41M-26.85%6.45M30.89%36.77M34.53%9.12M25.51%8.26M44.15%10.58M19.18%8.81M-38.92%28.09M-66.47%6.78M
Depreciation amortization depletion -60.00%4K-58.33%5K-66.67%6K-39.51%49K-55.56%8K-58.33%10K-42.86%12K0.00%18K-41.30%81K-47.06%18K
-Depreciation and amortization -60.00%4K-58.33%5K-66.67%6K-39.51%49K-55.56%8K-58.33%10K-42.86%12K0.00%18K-41.30%81K-47.06%18K
Operating profit 40.37%-6.97M49.18%-7.35M30.76%-9.76M-22.90%-52.36M-16.57%-12.13M-16.51%-11.68M-35.41%-14.45M-22.57%-14.1M34.91%-42.6M57.27%-10.4M
Net non-operating interest income expense -94.83%12K-71.47%93K-71.33%121K46.07%1.15M-57.36%171K-8.66%232K193.69%326K1,818.18%422K738.30%788K1,722.73%401K
Non-operating interest income -94.83%12K-71.47%93K-71.33%121K46.07%1.15M-57.36%171K-8.66%232K193.69%326K1,818.18%422K738.30%788K1,722.73%401K
Other net income (expense) 50.00%-1K77.78%-2K-50.00%1K140.00%2K0.00%-3K33.33%-2K-800.00%-9K0.00%2K
Gain on sale of security --------50.00%-1K77.78%-2K-50.00%1K140.00%2K0.00%-3K33.33%-2K-800.00%-9K0.00%2K
Income before tax 39.26%-6.95M48.67%-7.25M29.51%-9.64M-22.44%-51.21M-19.55%-11.96M-17.08%-11.45M-33.73%-14.13M-19.12%-13.68M36.01%-41.82M58.89%-10M
Income tax
Net income 39.26%-6.95M48.67%-7.25M29.51%-9.64M-22.44%-51.21M-19.55%-11.96M-17.08%-11.45M-33.73%-14.13M-19.12%-13.68M36.01%-41.82M58.89%-10M
Net income continuous Operations 39.26%-6.95M48.67%-7.25M29.51%-9.64M-22.44%-51.21M-19.55%-11.96M-17.08%-11.45M-33.73%-14.13M-19.12%-13.68M36.01%-41.82M58.89%-10M
Minority interest income
Net income attributable to the parent company 39.26%-6.95M48.67%-7.25M29.51%-9.64M-22.44%-51.21M-19.55%-11.96M-17.08%-11.45M-33.73%-14.13M-19.12%-13.68M36.01%-41.82M58.89%-10M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 39.26%-6.95M48.67%-7.25M29.51%-9.64M-22.44%-51.21M-19.55%-11.96M-17.08%-11.45M-33.73%-14.13M-19.12%-13.68M36.01%-41.82M58.89%-10M
Basic earnings per share 78.98%-0.3781.06%-0.4367.12%-0.73-11.47%-7.5811.66%-1.44-10.69%-1.76-31.98%-2.27-23.33%-2.2237.90%-6.859.75%-1.63
Diluted earnings per share 78.98%-0.3781.06%-0.4367.12%-0.73-11.47%-7.5811.66%-1.44-10.69%-1.76-31.98%-2.27-23.33%-2.2237.90%-6.859.75%-1.63
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--
Heat List
US
Overall
Symbol
Price
% Chg

No Data